Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(5):346; doi:10.1093/jnci/93.5.346-a
© 2001 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content

Journal of the National Cancer Institute, Vol. 93, No. 5, 346, March 7, 2001
© 2001 Oxford University Press

Correction

A story in the Nov. 15 News ("Do Follow-up Tests Actually Help Detect Recurrent Disease?" p. 1798–1800) suggested that the National Comprehensive Cancer Network recommends ultrasound screening for uterine cancer for women with breast cancer who are taking tamoxifen. The NCCN has never recommended the routine performance of ultrasound screening for uterine cancer for any group of women taking tamoxifen.





This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content